Miyahira Andrea K, Soule Howard R
Prostate Cancer Foundation, Santa Monica, CA.
Prostate. 2017 Jul;77(10):1093-1106. doi: 10.1002/pros.23366. Epub 2017 May 14.
The 23rd Annual Prostate Cancer Foundation (PCF) Scientific Retreat was convened October 27-29, 2016, in Carlsbad, CA.
This event focuses on the latest advances in basic, translational, and clinical prostate cancer research with the greatest promise for advancing our understanding of prostate cancer biology and improving patient outcomes and quality of life.
Themes highlighted at this year's meeting included: i) targeting DNA repair deficiency in prostate cancer; ii) optimizing the use of Radium-223 and bone-targeting agents; iii) advances in cancer immunotherapeutic approaches; iv) targeting developmental pathways in prostate cancer; v) advances in circulating tumor DNA technology and applications; vi) precision survivorship; and vii) novel treatments and treatment strategies in prostate cancer.
This article reviews the key advances discussed at the Retreat for the purpose of disseminating this knowledge to accelerate the development of new treatments and improved outcomes for men suffering with prostate cancer.
第23届前列腺癌基金会(PCF)科学研讨会于2016年10月27日至29日在加利福尼亚州卡尔斯巴德召开。
本次活动聚焦于基础、转化和临床前列腺癌研究的最新进展,这些进展最有希望增进我们对前列腺癌生物学的理解,并改善患者的治疗效果和生活质量。
今年会议突出的主题包括:i)针对前列腺癌中的DNA修复缺陷;ii)优化镭-223和骨靶向药物的使用;iii)癌症免疫治疗方法的进展;iv)针对前列腺癌中的发育途径;v)循环肿瘤DNA技术及应用的进展;vi)精准生存;以及vii)前列腺癌的新型治疗方法和治疗策略。
本文回顾了研讨会上讨论的关键进展,目的是传播这些知识,以加速新治疗方法的开发,并改善前列腺癌男性患者的治疗效果。